Venture Life Group PLC
(“Venture Life” or the “Company”)
Venture Life Group (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, is pleased to announce that Jerry Randall, CEO, will be presenting at an investor evening hosted by Turner Pope Investments ("TPI") Ltd.
TPI has been joint broker to Venture Life Group since September 2016. The event will be held on Monday 26 February in the City of London and will commence at 6pm. To Register your interest, please email email@example.com or call 0203 621 4120.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Turner Pope Investments (TPI) Ltd (Joint Broker) +44 (0) 20 3621 4120
James Pope / Ben Turner
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group’s product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women’s intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group’s international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.